Bay Harbor Wealth Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
QF
FCM
Bay Harbor Wealth Management's ROIV Position: Q2 2026 in Review
Bay Harbor Wealth Management increased its Roivant Sciences (ROIV) stake by 28% in Q2 2026, buying an estimated $384 and bringing the position to 60 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #634.
Bay Harbor Wealth Management first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Bay Harbor Wealth Management held 60 shares of Roivant Sciences worth $2.12K as of Q2 2026.
- Bay Harbor Wealth Management bought 13 Roivant Sciences shares in Q2 2026, an estimated $384.
- Roivant Sciences made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #634 holding.
- Bay Harbor Wealth Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
- 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.